# OnCo record paper-glofitamab-dlbcl-n-engl-j-med-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-glofitamab-dlbcl-n-engl-j-med-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-glofitamab-dlbcl-n-engl-j-med-2022" ;
  schema:name "Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma"@en ;
  schema:description "Phase 2 or 3 results paper on Glofitamab in Diffuse large B-cell lymphoma, in New England Journal of Medicine (2022), one of the most cited Europe PMC records with Glofitamab in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-glofitamab-dlbcl-n-engl-j-med-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa2206913>, <https://pubmed.ncbi.nlm.nih.gov/36507690/>, <https://europepmc.org/article/MED/36507690>, <https://clinicaltrials.gov/study/NCT03075696> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa2206913> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Dickinson MJ, Carlo-Stella C, Morschhauser F, et al." ;
  onco:trials <https://onco.cc/trials/nct03075696/> ;
  onco:journals <https://onco.cc/journals/nejm/> .